Mirae Asset Global Etfs Holdings Ltd. Viking Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 10,797 shares of VKTX stock, worth $322,074. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,797Holding current value
$322,074% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
468Shares Held
65.8MCall Options Held
5.84MPut Options Held
3.76M-
Vanguard Group Inc Valley Forge, PA10.2MShares$303 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$180 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$147 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$77.4 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$64.4 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.29B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...